The Association for Molecular Pathology (AMP) has released the preliminary results of its August 2020 SARS-CoV-2 Testing Survey for clinical laboratories. Respondents are experiencing continued supply chain interruptions and significant staffing shortages, all while demand for molecular diagnostic testing continues to increase.
↧